ARRAY BIOPHARMA INC|4Oct 29, 6:09 PM ET

Fyfe Gwen A. 4

4 · ARRAY BIOPHARMA INC · Filed Oct 29, 2018

Form 4

Period: 2018-10-25

Director

Transactions

Exercise/Conversion
Common Stock
2018-10-26+5,000→ 15,000 total
Award
Restricted Stock Units
2018-10-25+5,000→ 5,000 total
Exercise: $0.00→ Common Stock (5,000 underlying)
Award
Stock Option (Right to Buy)
2018-10-25+25,000→ 25,000 total
Exercise: $14.55Exp: 2028-10-25→ Common Stock (25,000 underlying)
Exercise/Conversion
Restricted Stock Units
2018-10-26−5,000→ 0 total
Exercise: $0.00→ Common Stock (5,000 underlying)

Footnotes (4)

[F1]Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by Array BioPharma Inc. ("Array") on October 26, 2017, as a result of the vesting of all such RSUs.
[F2]The options vest in full on October 25, 2019, subject to continued service on Array's board of directors.
[F3]RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock. The RSUs vest in full and will be settled in common stock on October 25, 2019, subject to continued service on Array's board of directors.
[F4]The RSUs vested and were settled in common stock on October 26, 2018.

Documents

1 file